Scientists say method could enable scale-up of induced neuron production for biomedical applications.
Chronic pain treatment program led by VM-902A, which the buyer plans to advance to Phase II enrollment early next year
AstraZeneca and MedImmune sign collaboration with mRNA therapeutics firm Ethris to develop stable, nonimmunogenic for respiratory diseases
ARGX-115 is a first-in-class human antibody targeting the novel immuno-oncology target GARP, a membrane protein believed to enhance the immunosuppressive effects of T cells
Pfizer is partially funding OPKO Health’s hGH-CTP development and commercialization initiatives in a deal that is potentially worth more than $570 million.
A University of Cambridge-led research team has shown how a prescription drug that is used to treat high blood pressure may represent a promising...
Labrys’ lead candidate, LBR-101, is in Phase IIb trials for prevention of chronic and high frequency episodic migraine.
Researchers engineer E. coli to produce new forms of popular antibiotic
Collaboration hinges on Insect Transformation Facility’s expertise in producing parasites in engineered mosquitoes.
Please wait while you are redirected to the right page...